Matches in Nanopublications for { ?s ?p "pimecrolimus cream 1 is indicated as second line therapy for the short term and non continuous chronic treatment of mild to moderate atopic dermatitis in non immunocompromised adults and children 2 years of age and older who have failed to respond adequately to other topical prescription treatments or when those treatments are not advisable pimecrolimus cream 1 is not indicated for use in children less than 2 years of age warnings and precautions 5 1 use in specific populations 8 4 pimecrolimus cream 1 is a calcineurin inhibitor immunosuppressant indicated as second line therapy for the short term and non continuous chronic treatment of mild to moderate atopic dermatitis in non immunocompromised adults and children 2 years of age and older who have failed to respond adequately to other topical prescription treatments or when those treatments are not advisable 1" ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- association label "pimecrolimus cream 1 is indicated as second line therapy for the short term and non continuous chronic treatment of mild to moderate atopic dermatitis in non immunocompromised adults and children 2 years of age and older who have failed to respond adequately to other topical prescription treatments or when those treatments are not advisable pimecrolimus cream 1 is not indicated for use in children less than 2 years of age warnings and precautions 5 1 use in specific populations 8 4 pimecrolimus cream 1 is a calcineurin inhibitor immunosuppressant indicated as second line therapy for the short term and non continuous chronic treatment of mild to moderate atopic dermatitis in non immunocompromised adults and children 2 years of age and older who have failed to respond adequately to other topical prescription treatments or when those treatments are not advisable 1" assertion.